0001367644-22-000063.txt : 20220412
0001367644-22-000063.hdr.sgml : 20220412
20220412160631
ACCESSION NUMBER: 0001367644-22-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220408
FILED AS OF DATE: 20220412
DATE AS OF CHANGE: 20220412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glessner Coleen
CENTRAL INDEX KEY: 0001919170
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 22822335
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_164979397671420.xml
FORM 4
X0306
4
2022-04-08
0
0001367644
Emergent BioSolutions Inc.
EBS
0001919170
Glessner Coleen
400 PROFESSIONAL DRIVE
SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Quality & Ethics, and CPL
Common Stock
2022-04-08
4
A
0
5913
0
A
5913
D
Common Stock
2022-04-08
4
A
0
5913
0
A
11826
D
Employee Stock Options (Right to Buy)
42.28
2022-04-08
4
A
0
23651
42.28
A
2029-04-07
Common Stock
23651.0
23651
D
Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
/s/ S. Scott Lieberman, Attorney-in-fact
2022-04-12